1.  Cui H, Wang N, Li H, Bian Y, Wen W, Kong X, Wang F. The dynamic shifts of IL-10-producing Th17 and IL-17-producing Treg in health and disease: a crosstalk between ancient "Yin-Yang" theory and modern immunology. Cell Commun Signal. 2024;22:99. DOI: 10.1186/s12964-024-01505-0.

2.  Cui H, Jin Y, Wang N, Liu H, Shu R, Wang J, Wang X, Jia B, Wang Y, Bian Y, et al. Mechanic evaluation of Wu-Mei-Pill on colitis-associated colorectal cancer: An integrated transcriptomics, metabolomics, and experimental validation study. Phytomedicine. 2024;128:155509. DOI: 10.1016/j.phymed.2024.155509.

3.  Wang J, Jia B, Miao J, Li D, Wang Y, Han L, Yuan Y, Zhang Y, Wang Y, Guo L, et al. An novel effective and safe model for the diagnosis of nonalcoholic fatty liver disease in China: gene excavations, clinical validations, and mechanism elucidation. J Transl Med. 2024;22:624. DOI: 10.1186/s12967-024-05315-3.

4.  Sun M, Li L, Niu Y, Wang Y, Yan Q, Xie F, Qiao Y, Song J, Sun H, Li Z, et al. PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism. Acta Pharm Sin B. 2023;13:157-173. DOI: 10.1016/j.apsb.2022.05.019.

5.  Xie F, Zhang H, Zhu K, Jiang CS, Zhang X, Chang H, Qiao Y, Sun M, Wang J, Wang M, et al. PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1. MedComm (2020). 2023;4:e245. DOI: 10.1002/mco2.245.

6.  Wang J, Chang H, Quan X, Dai X, Wang Y, Wang C, Zhang S, Shan C. A model for identification of potential phase-separated proteins based on protein sequence, structure and cellular distribution. Int J Biol Macromol. 2023;243:125196. DOI: 10.1016/j.ijbiomac.2023.125196.

7.  Zhang X, Zheng Y, Wang Z, Gan J, Yu B, Lu B, Jiang X. Melatonin as a therapeutic agent for alleviating endothelial dysfunction in cardiovascular diseases: Emphasis on oxidative stress. Biomed Pharmacother. 2023;167:115475. DOI: 10.1016/j.biopha.2023.115475.

8.  Zeng M, Zhang X, Lv N, Wang L, Suo Y, Gan J, Yang L, Yu B, Jiang X, Zeng W. Sodium Danshensu stabilizes atherosclerotic vulnerable plaques by targeting IKKbeta mediated inflammation in macrophages. Biomed Pharmacother. 2023;165:115153. DOI: 10.1016/j.biopha.2023.115153.

9.  Qi J, Cheng W, Gao Z, Chen Y, Shipton ML, Furkert D, Chin AC, Riley AM, Fiedler D, Potter B, et al. Itraconazole inhibits endothelial cell migration by disrupting inositol pyrophosphate-dependent focal adhesion dynamics and cytoskeletal remodeling. Biomed Pharmacother. 2023;161:114449. DOI: 10.1016/j.biopha.2023.114449.

10.  Yi B, Zhang S, Yan S, Liu Y, Feng Z, Chu T, Liu J, Wang W, Xue J, Zhang C, et al. Marsdenia tenacissima enhances immune response of tumor infiltrating T lymphocytes to colorectal cancer. Front Immunol. 2023;14:1238694. DOI: 10.3389/fimmu.2023.1238694.

11.  Zhang Q, Cao S, Qiu F, Kang N. Incomplete autophagy: Trouble is a friend. Med Res Rev. 2022;42:1545-1587. DOI: 10.1002/med.21884.

12.  Ma L, Li Q, Xie Y, Jianyuan Z, Yi D, Guo S, Guo F, Wang J, Yang L, Cen S. Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CL(pro). Antiviral Res. 2022;207:105419. DOI: 10.1016/j.antiviral.2022.105419.

13.  Yuan Y, Yang C, Wang Y, Sun M, Bi C, Sun S, Sun G, Hao J, Li L, Shan C, et al. Functional metabolome profiling may improve individual outcomes in colorectal cancer management implementing concepts of predictive, preventive, and personalized medical approach. EPMA J. 2022;13:39-55. DOI: 10.1007/s13167-021-00269-8.

14.  Huang P, Zuo Q, Li Y, Oduro PK, Tan F, Wang Y, Liu X, Li J, Wang Q, Guo F, et al. A Vicious Cycle: In Severe and Critically Ill COVID-19 Patients. Front Immunol. 2022;13:930673. DOI: 10.3389/fimmu.2022.930673.

15.  Fan Y, Dong W, Wang Y, Zhu S, Chai R, Xu Z, Zhang X, Yan Y, Yang L, Bian Y. Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease. Front Immunol. 2022;13:959495. DOI: 10.3389/fimmu.2022.959495.

16.  Ren Y, Miao JM, Wang YY, Fan Z, Kong XB, Yang L, Cheng G. Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option. Front Immunol. 2022;13:961796. DOI: 10.3389/fimmu.2022.961796.

17.  Yi J, Miao J, Zuo Q, Owusu F, Dong Q, Lin P, Wang Q, Gao R, Kong X, Yang L. COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses. Front Immunol. 2022;13:978619. DOI: 10.3389/fimmu.2022.978619.

18.  Li Q, Tan F, Wang Y, Liu X, Kong X, Meng J, Yang L, Cen S. The gamble between oncolytic virus therapy and IFN. Front Immunol. 2022;13:971674. DOI: 10.3389/fimmu.2022.971674.

19.  Wang J, Qiao Y, Sun M, Sun H, Xie F, Chang H, Wang Y, Song J, Lai S, Yang C, et al. FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1. Clin Transl Med. 2022;12:e772. DOI: 10.1002/ctm2.772.

20.  Zhao F, Xu F, Liu X, Hu Y, Wei L, Fan Z, Wang L, Huang Y, Mei S, Guo L, et al. SERINC5 restricts influenza virus infectivity. PLoS Pathog. 2022;18:e1010907. DOI: 10.1371/journal.ppat.1010907.

21.  Zeng M, Zhang R, Yang Q, Guo L, Zhang X, Yu B, Gan J, Yang Z, Li H, Wang Y, et al. Pharmacological therapy to cerebral ischemia-reperfusion injury: Focus on saponins. Biomed Pharmacother. 2022;155:113696. DOI: 10.1016/j.biopha.2022.113696.

22.  Xie L, Xu C, Fan Y, Li Y, Wang Y, Zhang X, Yu S, Wang J, Chai R, Zhao Z, et al. Effect of fecal microbiota transplantation in patients with slow transit constipation and the relative mechanisms based on the protein digestion and absorption pathway. J Transl Med. 2021;19:490. DOI: 10.1186/s12967-021-03152-2.

23.  Li Y, Liang R, Sun M, Li Z, Sheng H, Wang J, Xu P, Liu S, Yang W, Lu B, et al. AMPK-dependent phosphorylation of HDAC8 triggers PGM1 expression to promote lung cancer cell survival under glucose starvation. Cancer Lett. 2020;478:82-92. DOI: 10.1016/j.canlet.2020.03.007.